Department News

  • Start-Up Company Targets Muscular Dystrophy
    11/10/10

    The FDA has designated a peptide from tarantula venom as an orphan drug. UB biophysicist Frederick Sachs, PhD, hopes it will lead to development of a treatment for Duchenne muscular dystrophy.